Cargando…
Recent advances in inhibition of porcine reproductive and respiratory syndrome virus through targeting CD163
Porcine reproductive and respiratory syndrome virus (PRRSV) has plagued the pig industry for more than 30 years and causes great economic losses. At present different commercial vaccines are available but limited tools. Until now at least six potential host factors are identified as the key receptor...
Autores principales: | Zhang, Xiaoxiao, Guo, Chunhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522899/ https://www.ncbi.nlm.nih.gov/pubmed/36187992 http://dx.doi.org/10.3389/fmicb.2022.1006464 |
Ejemplares similares
-
Editorial: Porcine reproductive and respiratory syndrome virus—Microbiology and pathogenesis
por: Guo, Chunhe, et al.
Publicado: (2023) -
CD163(ΔSRCR5) MARC-145 Cells Resist PRRSV-2 Infection via Inhibiting Virus Uncoating, Which Requires the Interaction of CD163 With Calpain 1
por: Yu, Piao, et al.
Publicado: (2020) -
Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway
por: Zhu, Zhenbang, et al.
Publicado: (2020) -
Recent advances in the study of NADC34-like porcine reproductive and respiratory syndrome virus in China
por: Zhao, Hong-zhe, et al.
Publicado: (2022) -
Generation of Pigs Resistant to Highly Pathogenic-Porcine Reproductive and Respiratory Syndrome Virus through Gene Editing of CD163
por: Chen, Jingyao, et al.
Publicado: (2019)